A new Pfizer vaccine to prevent respiratory syncytial virus (RSV) in infants could be approved by the Food and Drug Administration by the end of the summer, according to officials. The vaccine, once approved and available to the public, would be administered to the pregnant mother while the unborn baby was in utero. The vaccine […]